| Literature DB >> 27294168 |
Johannes Barth1, Panagiotis Akritopoulos1, Nicolas Graveleau2, Renaud Barthelemy3, Cécile Toanen2, Mo Saffarini4.
Abstract
BACKGROUND: Osteoconductive additives are used in resorbable interference screws for anterior cruciate ligament (ACL) reconstruction to improve graft incorporation and mitigate adverse effects. There are no published studies that compare biological performances of bioresorbable and biocomposite screws without artifacts due to different follow-up times and intrinsic patient characteristics. PURPOSE/HYPOTHESIS: The purpose of this study was to evaluate the efficacy of osteoconductive agents in bioresorbable screws for ACL reconstruction at minimum follow-up of 2 years by intrapatient comparison. The hypothesis was that osteoconductive ceramics would result in slower resorption, improved ossification, and less tunnel widening. STUDYEntities:
Keywords: anterior cruciate ligament; biocomposite; bioresorbable; calcium phosphate; cortical formation; hxdroxyapatite; interference screws; resorption; tunnel widening
Year: 2016 PMID: 27294168 PMCID: PMC4892430 DOI: 10.1177/2325967116647724
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Patient Demographics
| Group A (n = 15; 56%) | Group B (n = 12; 44%) |
| |
|---|---|---|---|
| Age at surgery, y | 37.9 ± 10.9 (20.0-53.0) | 35.3 ± 11.1 (17.0-52.0) | NS |
| Follow-up, mo | 28.6 ± 2.3 (24.0-31.0) | 30.9 ± 5.1 (24.0-39.0) | NS |
| Male sex, n (%) | 8 (53) | 7 (58) | NS |
| IKDC score (preoperative), n (%) | NS | ||
| B | 1 (7) | 1 (8) | |
| C | 12 (80) | 11 (92) | |
| D | 2 (13) | 0 (0) |
Data are presented as mean ± SD (range) unless noted otherwise. IKDC, International Knee Documentation Committee; NS, not significant.
Figure 1.Screw resorption based on the visibility of the screw within the bone tunnel. (A) Intact, distinct, continuous, and homogenous solid; (B) visible, nonhomogenous solid with some dissolution; (C) ghost, diminished solid with considerable dissolution; and (D) resorbed, invisible, replaced by bone or scar tissue.
Figure 2.Tunnel widening compared with the screw tract. (A) None, unchanged; (B) figure-of-8; (C) enlarged, widening at some levels; and (D) wide, considerable widening at all levels.
Univariate Analysis of Radiographic Outcomes per Screw Type, Location, and Sex
| Biocomposite (PLDLLA + β-TCP + HA) (n = 27; 50%) | Bioresorbable (PLDLLA) (n = 27; 50%) |
| Femur (n = 27; 50%) | Tibia (n = 27; 50%) |
| Men (n = 28; 52%) | Women (n = 26; 48%) |
| |
|---|---|---|---|---|---|---|---|---|---|
| Resorption | .0029 | .0587 | NS | ||||||
| Intact | 8 (30) | 2 (7) | 6 (22) | 4 (15) | 4 (14) | 6 (23) | |||
| Visible | 7 (26) | 1 (4) | 7 (26) | 1 (4) | 3 (11) | 5 (19) | |||
| Ghost | 2 (7) | 2 (7) | 2 (7) | 2 (7) | 2 (7) | 2 (8) | |||
| Resorbed | 10 (37) | 22 (81) | 12 (44) | 20 (74) | 19 (68) | 13 (50) | |||
| Ossification (Barber) | .0216 | NS | NS | ||||||
| 1 | 8 (30) | 16 (59) | 10 (37) | 14 (52) | 9 (32) | 15 (58) | |||
| 2 | 5 (19) | 7 (26) | 8 (30) | 4 (15) | 6 (21) | 6 (23) | |||
| 3 | 10 (37) | 4 (15) | 7 (26) | 7 (26) | 10 (36) | 4 (15) | |||
| 4 | 4 (15) | 0 (0) | 2 (7) | 2 (7) | 3 (11) | 1 (4) | |||
| Tunnel widening | .0126 | <.0001 | NS | ||||||
| None, unchanged | 22 (81) | 13 (48) | 26 (96) | 9 (33) | 19 (68) | 16 (62) | |||
| Figure-of-8 | 2 (7) | 11 (41) | 1 (4) | 12 (44) | 7 (25) | 6 (23) | |||
| Enlarged at some levels | 1 (4) | 1 (4) | 0 (0) | 2 (7) | 0 (0) | 2 (8) | |||
| Wide at all levels | 2 (7) | 2 (7) | 0 (0) | 4 (15) | 2 (7) | 2 (8) | |||
| Cortical formation | .0012 | .0012 | NS | ||||||
| Absent | 0 (0) | 8 (30) | 0 (0) | 8 (30) | 3 (11) | 5 (19) | |||
| Thin | 6 (22) | 9 (33) | 6 (22) | 9 (33) | 9 (32) | 6 (23) | |||
| Marked | 21 (78) | 10 (37) | 21 (78) | 10 (37) | 16 (57) | 15 (58) |
Data presented as n (%). β-TCP, β–tricalcium phosphate; HA, hydroxyapatite; NS, not significant; PLDLLA, poly(l-lactide-co-d,l-lactide).
Barber classification grades: 1 = little or none; 2 = some, discontinuous; 3 = thin lucent rim; 4 = good.
Bivariate Analysis of Radiographic Outcomes per Screw Type and Location
| Femur | Tibia | |||||
|---|---|---|---|---|---|---|
| Biocomposite (PLDLLA + β-TCP + HA) (n = 15; 56%) | Bioresorbable (PLDLLA) (n = 12; 44%) |
| Biocomposite (PLDLLA + β-TCP + HA) (n = 12; 44%) | Bioresorbable (PLDLLA) (n = 15; 56%) |
| |
| Resorption | .0202 | NS | ||||
| Intact | 5 (33) | 1 (8) | 3 (25) | 1 (7) | ||
| Visible | 6 (40) | 1 (8) | 1 (8) | 0 (0) | ||
| Ghost | 1 (7) | 1 (8) | 1 (8) | 1 (7) | ||
| Resorbed | 3 (20) | 9 (75) | 7 (58) | 13 (87) | ||
| Ossification (Barber) | NS | <.0001 | ||||
| 1 | 6 (40) | 4 (33) | 2 (17) | 12 (80) | ||
| 2 | 4 (27) | 4 (33) | 1 (8) | 3 (20) | ||
| 3 | 3 (20) | 4 (33) | 7 (58) | 0 (0) | ||
| 4 | 2 (13) | 0 (0) | 2 (17) | 0 (0) | ||
| Tunnel widening | NS | .0227 | ||||
| None, unchanged | 15 (100) | 11 (92) | 7 (58) | 2 (13) | ||
| Figure-of-8 | 0 (0) | 1 (8) | 2 (17) | 10 (67) | ||
| Enlarged at some levels | 0 (0) | 0 (0) | 1 (8) | 1 (7) | ||
| Wide at all levels | 0 (0) | 0 (0) | 2 (17) | 2 (13) | ||
| Cortical formation | NS | <.0001 | ||||
| Absent | 11 (73) | 10 (83) | 10 (83) | 0 (0) | ||
| Thin | 4 (27) | 2 (17) | 2 (17) | 7 (47) | ||
| Marked | 0 (0) | 0 (0) | 0 (0) | 8 (53) | ||
Data presented as n (%). β-TCP, β–tricalcium phosphate; HA, hydroxyapatite; NS, not significant; PLDLLA, poly(l-lactide-co-d,l-lactide).
Barber classification grades: 1 = little or none; 2 = some, discontinuous; 3 = thin lucent rim; 4 = good.